Home  |  Contact

Cellosaurus NYH/VM (CVCL_0B29)

[Text version]
Cell line name NYH/VM
Synonyms OC-NYH/VM
Accession CVCL_0B29
Resource Identification Initiative To cite this cell line use: NYH/VM (RRID:CVCL_0B29)
Comments Selected for resistance to: ChEBI; CHEBI:75988; Teniposide (VM-26).
Derived from site: Metastatic; Pleural effusion; UBERON=UBERON_0000175.
Disease Lung small cell carcinoma (NCIt: C4917)
Small cell lung cancer (ORDO: Orphanet_70573)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_8207 (GLC-2)
Sex of cell Male
Age at sampling 41Y
Category Cancer cell line
Publications

PubMed=8390259; DOI=10.1016/0006-2952(93)90013-M
Jensen P.B., Sorensen B.S., Sehested M., Demant E.J.F., Kjeldsen E., Friche E., Hansen H.H.
Different modes of anthracycline interaction with topoisomerase II Separate structures critical for DNA-cleavage, and for overcoming topoisomerase II-related drug resistance.
Biochem. Pharmacol. 45:2025-2035(1993)

PubMed=9062409; DOI=10.1038/bjc.1997.154
Jensen P.B., Holm B., Sorensen M., Christensen I.J., Sehested M.
In vitro cross-resistance and collateral sensitivity in seven resistant small-cell lung cancer cell lines: preclinical identification of suitable drug partners to taxotere, taxol, topotecan and gemcitabin.
Br. J. Cancer 75:869-877(1997)

Cross-references
Encyclopedic resources Wikidata; Q54931220
Entry history
Entry creation10-Apr-2015
Last entry update29-Jun-2023
Version number8